Agilent this week reported fourth-quarter revenues of $1.58 billion, including $431 million in revenues from its Life Science Group, a 35-percent jump from $319 million in the fourth quarter of 2009.

According to CEO Bill Sullivan, the company's life sciences platforms all posted double-digit sales increases with the company's liquid chromatography instruments up 21 percent, led by the strong performance of its 1290 and 1260 Infinity LC lines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.